title: In-office Painless Aminolevulinic Acid Photodynamic Therapy: A Proof of Concept Study and Clinical Experience in More Than 100 Patients.
abstract: OBJECTIVE
  To evaluate the efficacy, safety, and pain of in-office "painless" aminolevulinic acid photodynamic therapy aimed at decreasing treatment-associated pain in patients undergoing removal of actinic keratoses.
  
  
  METHODS
  Prospective split-face study comparing short aminolevulinic acid incubation times of 15 minutes followed by extended exposure (60 minutes) of continuous blue light versus conventional aminolevulinic acid photodynamic therapy. Prospective assessment of pain in patients undergoing in-office "painless" aminolevulinic acid photodynamic therapy.
  
  
  METHODS
  Clinical practice office.
  
  
  METHODS
  Three patients with actinic keratoses participated in the split-face study and 101 in the pain assessment study.
  
  
  METHODS
  Evaluations in the split-face study included removal of actinic keratoses, skin temperature, and pain measured on a 10-point visual analog scale. Pain was assessed using the visual analog scale in the pain assessment study.
  
  
  RESULTS
  In the split-face study, in-office "painless" aminolevulinic acid photodynamic therapy resulted in a 52-percent reduction in lesions versus 44 percent for conventional aminolevulinic acid photodynamic therapy. Maximum pain scores of in-office "painless" aminolevulinic acid photodynamic therapy were all 0 at each time point, and the average score for conventional aminolevulinic acid photodynamic therapy was 7. Baseline skin temperatures increased from a baseline of 29 to 32°C to 34 to 35°C by minute 10 of blue light activation on both sides of the face. RESULTS from the pain assessment study indicated no or minimal (scores 0-2) pain in nearly all patients who received in-office "painless" aminolevulinic acid photodynamic therapy as monotherapy or in combination with 5-fluoruacil or imiquimod used as pretreatments.
  
  
  CONCLUSIONS
  In-office "painless" aminolevulinic acid photodynamic therapy appears to be effective for removing actinic keratoses and is associated with little or no pain in nearly all patients. This procedure should be evaluated in large-scale controlled trials.
authors.affiliation: Dr. George Martin Dermatology Associates, Kihei, Maui, Hawaii.
authors.forename: George M
authors.initials: GM
authors.lastname: Martin